The Follow the Science Act amends the Public Health Service Act to insulate NIH decisionmaking and extramural funding from participation by most political appointees. It adds a statutory definition of “political employee,” expressly prohibits those individuals from employment at NIH and from participating in policy implementation, and bars their involvement in solicitation, review, scoring, selection, or awarding of grants, contracts, cooperative agreements, other transactions, or funding arrangements.
The bill preserves three exceptions: the Director of NIH, the Director of the National Cancer Institute, and the Director of the Advanced Research Projects Agency for Health (ARPA‑H).
The bill also restricts NIH’s ability to cancel, delay, or suspend awards: NIH may take those steps only after issuing written findings of financial mismanagement, research fraud, debarment, or malfeasance and must notify key congressional committees within 30 days. Finally, the Director must provide Congress a retrospective accounting of political‑employee participation in relevant NIH processes dating back to January 20, 2021.
For compliance officers and research administrators, the Act creates new hiring limits, documentation thresholds for stopping awards, and a statutory basis to challenge perceived political interference in research funding.
At a Glance
What It Does
The bill adds a statutory definition of “political employee” and forbids those employees from working at NIH or taking part in policy implementation; it also bars them from participating in the solicitation, review, scoring, selection, or awarding of NIH and ARPA‑H funding instruments. Separately, it prevents NIH from cancelling or suspending awards except with written findings of specific wrongdoing and with a 30‑day congressional notification.
Who It Affects
NIH hiring and personnel practices, extramural grants and contracts staff, university and research grantees, ARPA‑H program offices, HHS Office of the General Counsel, and grants and contracting officers who manage award lifecycle actions (including use of the Payment Management System).
Why It Matters
The Act transforms personnel boundaries into statutory constraints and raises the evidentiary bar for administrative actions that interrupt funding. That combination reduces the levers available to political leadership to direct or quickly reassign NIH funding and creates new documentary and reporting obligations for the agency and its managers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill first expands the Public Health Service Act’s definitions to create a single, broad category: “political employee.” That term reaches presidential Schedule positions (5 U.S.C. 5312–5316), noncareer Senior Executive Service appointees, schedule C confidential/policy positions, Schedule G appointees established by Executive Order 14317, and any position otherwise excepted from competitive service because of its policy character. It also captures people acting on behalf of those appointees.
This is a wide net intended to move beyond a few headline titles and to capture many political hires who could otherwise influence program direction.
On the operational side, the bill bars those political employees — with three narrow exceptions (NIH Director, NCI Director, ARPA‑H Director) — from employment at NIH and from participating in “implementation of general policies respecting the management and operation of programs and activities” at NIH. Separately, it requires the Secretary, through the NIH Director, to ensure political employees do not take part in solicitation, review, scoring, selection, or award decisions for grants, contracts, cooperative agreements, other transactions, or other funding arrangements.
The text preserves cross‑references to existing statutory authorities (it expressly says its rules should not be read to affect sections 406 or 492 of the Public Health Service Act), which keeps some preexisting appointment or oversight rules intact.The bill adds two practical guardrails for the extramural portfolio. First, the Director must produce a report to Congress within 30 days of enactment accounting for any political‑employee participation in awards decisions from January 20, 2021 through enactment.
Second, NIH may not cancel, delay, or suspend a covered agreement — and may not rely on the Payment Management System to choke off funding — unless the agency issues written findings documenting financial mismanagement, research fraud, debarment, or malfeasance. If NIH suspends or cancels an award it must notify the House Energy and Commerce Committee and the Senate HELP Committee with those findings within 30 days.
The bill also requires covered agreements to be implemented according to their terms and for the full period specified, which limits unilateral, programmatic pauses or terminations without the stated findings.Taken together, the bill converts widely‑used administrative practices (temporary reassignments of decision authority, interagency detailees participating in peer review, stop‑work or stop‑payment actions) into events that now require either explicit statutory exception or documented, findable misconduct. That will force NIH and its grants management components to clarify what constitutes permissible policy input, revise stewardship and conflict‑of‑interest controls, and codify new paperwork and review trails to justify any award interruption.
The Five Things You Need to Know
The bill adds a new subsection to the Public Health Service Act that defines “political employee” to include Executive Schedule positions (5 U.S.C. 5312–5316), noncareer SES appointees (5 U.S.C. 3132(a) noncareer), schedule C positions (5 C.F.R. part 213, subpart C), Schedule G appointees (Executive Order 14317), and any other positions excepted from competitive service for policy reasons.
Except for three named officials (NIH Director, NCI Director, and ARPA‑H Director), the statute prohibits political employees from employment at NIH and from participating in implementation of general policies governing NIH management and operations.
The Secretary, through the NIH Director, must ensure political employees do not participate in solicitation, review, scoring, selection, or awarding of NIH or ARPA‑H grants, contracts, cooperative agreements, other transactions, or other funding arrangements.
The Director must deliver to Congress — within 30 days of enactment — an accounting of political‑employee participation in the specified NIH funding activities going back to January 20, 2021 and ending on the enactment date.
NIH may not cancel, delay, or suspend a covered agreement (including via the Payment Management System) unless it issues written findings of financial mismanagement, research fraud, debarment, or malfeasance and notifies House Energy and Commerce and Senate HELP committees within 30 days; covered agreements must be implemented per their terms and for the full period specified.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Names the statute the “Follow the Science Act.” This is the conventional short‑title clause; it creates no substantive obligations but signals legislative intent to prioritize scientific decision‑making in the statute’s construction.
Statutory definition of political employee
Adds a new subsection to the Public Health Service Act that sets out a broad statutory definition of “political employee.” Practically, this locks a personnel boundary into statute rather than leaving it to executive‑branch policy; it covers multiple appointment authorities and any agent acting on their behalf. For HR and classification shops this will require re‑review of position descriptions, hiring pathways, and detailee agreements to determine which roles are now statutorily barred from NIH participation.
Bars political appointees from NIH employment and policy implementation
Creates a new prohibition at section 401(g) of the PHS Act: other than the three named directors, political employees may not work for NIH or participate in implementing general NIH management policies. The provision leaves two visible gaps: (1) the three named Director exceptions remain political positions that can exercise authority at NIH, and (2) it preserves other statutory authorities by saying it does not affect sections 406 and 492, which means preexisting appointment or oversight mechanisms continue to operate. Compliance teams will need to map who currently performs “implementation” functions to determine what work must be insulated from political staff.
Bars political employees from handling awards; requires retrospective accounting
Amends section 402 to require the Secretary, through the NIH Director, to keep political employees out of solicitation, review, scoring, selection, and awarding of grants, contracts, cooperative agreements, other transactions, and funding arrangements at NIH and ARPA‑H. The section adds an exception when participation is ‘specifically required under this title’ and preserves the noninterference language with respect to sections 406 and 492. It also mandates a post‑enactment report to Congress accounting for political‑employee participation in such activities from January 20, 2021 to the date of enactment; that report is an immediate compliance deliverable that will demand internal record searches across grants, contracting, and detail agreements.
Limits on cancelling or suspending awards; implementation requirements
Adds a separate amendment limiting NIH’s authority to cancel, delay, or suspend covered agreements — defined to include grants, contracts, cooperative agreements, and other transactions — except where written findings document financial mismanagement, research fraud, debarment, or malfeasance. If NIH cancels or suspends an award it must notify the House Energy and Commerce Committee and Senate HELP Committee within 30 days and include the findings. The section also directs that covered agreements must be executed according to their terms and for the full period specified, which constrains use of administrative stop-pay measures and requires clearer written justification for any interruption.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Extramural investigators and grantees — universities and research institutions gain statutory protection against sudden, politically motivated interruptions to funding and clearer criteria for when NIH may pause or terminate awards.
- NIH scientific staff and career managers — insulated decision‑making reduces risk that technical program choices will be overruled by political hires, improving predictability for program design and peer‑review integrity.
- Research integrity advocates and professional scientific societies — the law establishes a statutory floor for separating political personnel from technical award processes, supporting public arguments for independence in research funding.
Who Bears the Cost
- Political appointees and White House‑chosen detailees — the bill removes many channels through which political staff previously influenced NIH policy or funding decisions, narrowing their operational role.
- NIH grants and contract management offices — staff will face increased administrative burdens to document justifications for any award suspension or cancellation and to demonstrate compliance with the prohibition on political participation.
- HHS/agency legal and HR units — offices of counsel and human resources must interpret the new definition, adjust position classifications and detailee agreements, and field the mandated congressional accounting and committee notifications.
Key Issues
The Core Tension
The bill balances two legitimate goals that pull in opposite directions: protecting scientific decisionmaking and grantee stability from political interference, versus preserving executive‑branch flexibility to direct programs and to act quickly in unusual or urgent circumstances. Raising the evidentiary and procedural bar for stopping awards strengthens scientific autonomy but also reduces the administration’s discretionary tools to reallocate or pause funding when policymakers believe a non‑fraud reason justifies action.
The Act raises immediate implementation questions. The statutory definition of “political employee” is broad and will require HHS to reclassify or reallocate staff tasks across a range of appointment authorities; that work will touch hundreds of positions and interagency detailees.
The bill’s operational effect will depend on how the agency interprets “participate in the implementation of general policies” — a phrase that can be read narrowly (literal execution of management directives) or broadly (any supervisory or advisory role that shapes program priorities). That interpretive choice will determine whether commonly used interagency collaborations, briefings for political leadership, or program oversight activities become restricted.
The cancellation rule sets a high evidentiary bar for stopping funding — written findings of mismanagement, fraud, debarment, or malfeasance — which protects grantees but may hinder rapid agency responses to emergent legal or policy concerns. For example, if NIH identifies compelling but non‑fraudulent reasons to pause an award (national security vetting, urgent public‑health reassessment, or conflicts of interest not rising to debarment), the statute does not explicitly provide a pathway to act without the specified findings.
The requirement to notify two congressional committees within 30 days creates political accountability, but it also institutionalizes a post‑hoc review that could deter prudent, time‑sensitive administrative actions. Lastly, the bill omits explicit enforcement mechanisms — there are no civil penalties, private right of action, or clear inspector general triggers tied to these provisions — so compliance will largely rest on internal agency controls and congressional oversight.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.